SafePAS

The Drug Hunter portable analyzer by SafePAS requires minimal training, with operators typically needing just one day to learn its use.

SafePAS invites partners to become Drug Hunter distributors, offering CE and fluorescence-based drug detection with accurate results.

Drug Hunter is a portable saliva drug analyzer that identifies and quantifies drugs on site, helping law enforcement avoid false-positive preselection and unnecessary blood tests.

The Drug Hunter process includes self-diagnostics, sampling, filtration, and analysis, delivering lab-grade, quantitative results in minutes.

The Drug Hunter portable drug analyzer provides fast, accurate saliva tests at roadside and workplace settings. Its non-invasive on-site results improve safety.

Germany’s new THC driving limit follows changes to cannabis laws, but many roadside drug tests still function as binary screening tools. This creates risks of false positives, unnecessary blood tests, and wasted police and lab resources.

Estonian deeptech startup SafePAS raises €700k to expand Drug Hunter, a portable drug testing analyzer delivering fast, accurate saliva-based drug detection for law enforcement and workplaces.

SafePAS and its Drug Hunter technology recognized at the 2023 Europol Excellence Awards in Innovation for advancing rapid, on-site drug detection and improving public safety technologies.

SafePAS secures €2.5M EIS grant to accelerate global rollout of DrugHunter, a portable drug testing analyzer delivering fast, quantitative saliva analysis for law enforcement and public safety.

SafePAS participates in the General Police Equipment Exhibition & Conference (GPEC) in Leipzig, Germany, from May 20–22, 2026.

SafePAS’s scientists, with PhDs and decades of R&D experience, develop portable, lab-grade analyzers for drug testing to improve safety.

SafePAS originated in Estonia and created portable systems for saliva drug analysis and soil intelligence, reducing false positives and guesswork.

Contact SafePAS for a personalised demo of Drug Hunter and SMAGRY or to discuss partnership. Email info@safepas.eu – response within one business day

SafePAS builds portable analytical systems for on-site drug testing and soil analysis, helping teams reduce false positives, cut waste, and make faster decisions.

SafePAS, an Estonian startup, develops portable analytical systems for on-site drug testing. The company originated from a 2019 Tallinn University of Technology research project at a Latvian music festival, where a prototype detected dangerously high ecstasy levels in a 15-year-old attendee’s saliva. The case prompted an ambulance response and highlighted the system’s potential to enable faster emergency intervention for drug overdoses.

Sep 2026Research In EstoniaNews article

Estonian researchers develop a portable drug analyzer that detects both substances and their quantities within 15 minutes. The device generates rapid on-site results, addressing urgent public health and law enforcement needs. Early adopters and global institutions are showing growing interest in the technology.

Sep 2026ERRNews article

SafePAS develops instant saliva testing technology. The Estonian startup secures a €2.5 million EU-backed grant to expand its technology globally. The funding supports scaling efforts for its diagnostic solutions.

Sep 2025Invest in EstoniaNews article

SafePAS secures a **€2.5 million grant** from Estonia’s Enterprise and Innovation Fund (EIS) to advance its **DrugHunter rapid drug test**. The funding follows recognition under the **European Innovation Council’s (EIC) Seal of Excellence**, validating the technology’s innovation potential. The company now scales development with public-sector support.

Sep 2025balticvc.comNews article